All studies
RecruitingTherapeutic use (Phase IV)Interventional

Tranexamic Acid for reduction of intra- and postoperative TRansfusion Requirements in elective Abdominal surgery: randomized controlled trial (TATRA)

Major planned operations on the abdomen—such as surgery on the bowel, stomach, liver, gullet, or pancreas—carry a risk of heavy bleeding. When patients lose significant amounts of blood, they often need a blood transfusion to help them recover. This trial is testing a medicine called tranexamic acid, which is already used in other types of surgery to help blood clots stay stable and reduce blood loss. Patients taking part are randomly chosen to receive either tranexamic acid or a plain saltwater drip during their operation. Researchers will monitor how much blood patients lose, whether they need a transfusion, and how smoothly they recover over the following month. The aim is to find out if this simple treatment makes major abdominal surgery safer and cuts down the need for blood transfusions.

At a glance

Status
Recruiting
Phase
Therapeutic use (Phase IV)
Sponsor
Martin-Luther-Universitaet Halle-Wittenberg
Enrolment target
850
Start
25 Apr 2024

What is this study about?

Having major surgery on organs inside your tummy (abdomen)—such as the stomach, bowel, liver, or pancreas—is a significant event. Because these organs have a rich blood supply, these operations can sometimes cause heavy blood loss. If this happens, doctors must give the patient a blood transfusion using donor blood. While transfusions are safe and life-saving, avoiding unnecessary transfusions is always better for healing and reduces strain on donor blood supplies.

Tranexamic acid is an established, low-cost medicine that slows down the natural breakdown of blood clots. It is already widely used to stop bleeding after accidents, childbirth, and joint replacements. However, doctors want more reliable evidence to see if it is just as helpful and safe for patients having major planned abdominal surgery.

In this study, doctors are comparing tranexamic acid directly against a harmless saltwater (placebo) drip. By comparing the two groups, the study team can clearly see whether tranexamic acid genuinely reduces bleeding, shortens hospital stays, and lowers complication rates without causing unexpected side effects.

Key takeaways

  • Tests whether tranexamic acid lowers blood loss during major tummy operations.
  • Aims to reduce the need for donor blood transfusions during and after surgery.
  • Given as a simple drip while you are asleep in the operating theatre.
  • Open to adults aged 18 and over having planned abdominal surgery.
  • Tracks your recovery and safety for up to 30 days after surgery.

Who may be eligible?

This trial is open to adults aged 18 and over who are due to have a planned (elective) major operation on their abdomen. This includes surgeries on the gullet (oesophagus), stomach, bowel, rectum, pancreas, or liver. Both men and women can take part.

Because this study looks only at planned operations, people having emergency surgery cannot join. Your surgical team will check whether your specific type of planned operation is suitable for the study.

People with severe kidney problems, a known allergy to tranexamic acid, or a very high risk of blood clots may not be able to participate. Your hospital doctor will review your full medical history before you join to make sure it is safe for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I am scheduled for a planned (elective) major tummy or bowel operation.
  3. My operation is on my gullet, stomach, bowel, rectum, liver, or pancreas.
  4. My surgery is planned in advance, not an emergency procedure.
  5. I do not have a known allergy to tranexamic acid.
Answer every question to see your result.

What does participation involve?

If you decide to take part, you will be placed into one of two groups by chance (like flipping a coin). One group receives tranexamic acid through a vein during surgery, while the other group receives a standard saltwater drip. Neither you nor your surgical team will know which drip you are receiving, ensuring the results are fair.

All treatments are given in the operating theatre while you are asleep under general anaesthetic. You will not need any extra operations. While you recover on the hospital ward, the study team will track your blood test results, monitor your healing, and record whether you need a blood transfusion.

You will be followed up while you remain in hospital and up to 30 days after your operation to check on your recovery and overall well-being. Taking part does not require extra hospital visits beyond your normal surgical follow-up care.

Potential risks and benefits

If you receive tranexamic acid, you may benefit from less bleeding and a lower chance of needing a blood transfusion. However, this cannot be guaranteed, and you might receive the saltwater drip instead. Tranexamic acid is generally well tolerated, but it can occasionally cause mild side effects such as nausea or tummy upset. There is also a very small risk of developing an unwanted blood clot in the legs or lungs, though doctors will monitor you closely to prevent this. Taking part is completely voluntary, and you can withdraw at any time without your standard medical care being affected in any way.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Germany

Common questions

What is tranexamic acid?

It is a medicine that helps blood clots hold together, stopping bleeding more quickly.

Will taking part delay my surgery?

No. The study treatment is given during your already scheduled operation, so your surgery date will not change.

Will I definitely receive the study medicine?

No. A computer randomly decides whether you get tranexamic acid or a plain saltwater drip.

What happens if I need a blood transfusion during the trial?

Your safety always comes first. If your doctors decide you need blood, you will receive a transfusion immediately.

Can I leave the study if I change my mind?

Yes. You can leave the study at any point without giving a reason, and it will not affect your standard NHS care.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Tranexamic Acid for reduction of intra- and postoperative TR…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.